Clinical Trials Logo

Filter by:
NCT ID: NCT06121687 Not yet recruiting - Clinical trials for Erectile Dysfunction

Shaeer's Vein Ligation-I: Internal Pudendal Vein Sub-Gluteal Ligation For Veno Occlusive Erectile Dysfunction

Shaeer-I
Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this interventional study is to evaluate a new surgical technique (Shaeer's Sub-Gluteal Internal Pudendal Vein Ligation (SHAEER-I)) in patients with deep system veno-occlusive erectile dysfunction (VOD) . The main question[s] it aims to answer are: - [Will the patients have satisfactory rigidity after surgery] - [What will the Satisfaction rates be] - [Will there be complications] Participants will - Undergo SHAEER-I or PPI surgery - Report the results of surgery for at least 6 months

NCT ID: NCT06121674 Not yet recruiting - Clinical trials for Erectile Dysfunction

Shaeer's Vein Ligation-II: Internal Pudendal Vein Perineal Ligation For Veno Occlusive Erectile Dysfunction

Shaeer-II
Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this interventional study is to evaluate a new surgical technique (Shaeer's Perineal Internal Pudendal Vein Ligation (SHAEER-II)) in patients with deep system veno-occlusive erectile dysfunction (VOD) . The main question[s] it aims to answer are: - [Will the patients have satisfactory rigidity after surgery] - [What will the Satisfaction rates be] - [Will there be complications] Participants will - Undergo SHAEER-II or PPI surgery - Report the results of surgery for at least 6 months

NCT ID: NCT06119932 Not yet recruiting - Subdural Hematoma Clinical Trials

Evaluation of One Burr Hole Evacuation for Subdural Hematoma

Start date: November 1, 2023
Phase:
Study type: Observational

To evaluate the outcome of one burrhole evacuation for subdural hematoma and it has the same result of traditional two burrhole

NCT ID: NCT06113900 Not yet recruiting - Lupus Nephritis Clinical Trials

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Start date: December 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to assess the safety and efficacy of SGLT2is among LN patients.

NCT ID: NCT06113029 Not yet recruiting - Depression, Anxiety Clinical Trials

Depressive and Anxiety Disorders in Patients With Chronic Liver Diseases

Start date: December 1, 2023
Phase:
Study type: Observational

The aim of this observational study is to learn about the prevalence of depressive and anxiety disorders among patients with chronic liver diseases

NCT ID: NCT06112223 Not yet recruiting - Postoperative Pain Clinical Trials

Preemptive Oral Gabapentin and Tramadol on Postoperative Pain After Knee Arthroscopy

Start date: November 10, 2023
Phase: N/A
Study type: Interventional

The aim of this study to evaluate the effect of preemptive oral gabapentin versus tramadol on postoperative pain after knee arthroscopy under spinal anesthesia.

NCT ID: NCT06108622 Not yet recruiting - Clinical trials for Dermatologic Disorders With Heamatologic Malignancies Patients

Prevelance Of Cutaneous Disorders Among Patients With Heamatologic Malignancies

Start date: November 2023
Phase:
Study type: Observational

Hematologic malignancies are a diverse group of neoplasms that can have a wide range of clinical and behavioral characteristics. Infections are also a common complication of hematologic malignancies, and can manifest as cutaneous eruptions. Hair loss is a common symptom of hematological malignancies. Changes in the nails can also occur in patients with hematological malignancies. Chemotherapy and radiotherapy are two common treatments for hematological malignancies. patients may experience a wide range of side effects, including hair loss, changes in the nails, and mucositis (

NCT ID: NCT06103981 Not yet recruiting - Pneumonia Clinical Trials

Acute Liver Injury in Patients With Pneumonia

Start date: December 1, 2023
Phase:
Study type: Observational

Acute liver injury (ALI) is defined as an acute derangement in liver function tests associated with liver-related coagulopathy, in the absence of underlying chronic liver disease. A subset progress to acute liver failure ,Acute liver failure represent a more severe liver injury results in hepatic encephalopathy

NCT ID: NCT06102252 Not yet recruiting - Clinical trials for Endometrial Carcinoma

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as an Adjuvant Treatment in Endometrial Carcinoma

Start date: November 2023
Phase: N/A
Study type: Interventional

Endometrial cancer, the most common gynecologic cancer worldwide, is steadily increasing in developed countries.The early-stage forms of endometrial cancer are usually highly curable by surgical treatment alone, whereas advanced stages require adjuvant interdictions such as radiotherapy and chemotherapy. Platinum and anthracycline drugs have long been used as standard adjuvant chemotherapy drugs for advanced and recurrent endometrial carcinomas. In one study, the standard combination adjuvant treatment with AP was found to be more effective as an adjuvant therapy than whole abdominal irradiation

NCT ID: NCT06100640 Not yet recruiting - Placenta Accreta Clinical Trials

Paracervical Pouch in Placenta Accreta Spectrum

pouch
Start date: October 30, 2023
Phase:
Study type: Observational

The study objective is the significance of the ultrasound detection of the paracervical pouch in placenta accreta spectrum. It aimed to evaluate its relation to the degree of placenta accreta spectrum, amount of the blood loss and the number of packed red blood cells transfused.